Logo image of IINN

INSPIRA TECHNOLOGIES OXY BHN (IINN) Stock Fundamental Analysis

NASDAQ:IINN - Nasdaq - IL0011715781 - Common Stock - Currency: USD

0.73  +0 (+0.55%)

Premarket: 0.6902 -0.04 (-5.45%)

Fundamental Rating

1

Taking everything into account, IINN scores 1 out of 10 in our fundamental rating. IINN was compared to 188 industry peers in the Health Care Equipment & Supplies industry. While IINN seems to be doing ok healthwise, there are quite some concerns on its profitability. IINN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year IINN has reported negative net income.
IINN had a negative operating cash flow in the past year.
IINN had negative earnings in each of the past 5 years.
IINN had a negative operating cash flow in each of the past 5 years.
IINN Yearly Net Income VS EBIT VS OCF VS FCFIINN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

The Return On Assets of IINN (-136.96%) is worse than 87.77% of its industry peers.
IINN has a Return On Equity of -255.74%. This is in the lower half of the industry: IINN underperforms 78.19% of its industry peers.
Industry RankSector Rank
ROA -136.96%
ROE -255.74%
ROIC N/A
ROA(3y)-107.44%
ROA(5y)-223.64%
ROE(3y)-177.51%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IINN Yearly ROA, ROE, ROICIINN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

1.3 Margins

IINN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IINN Yearly Profit, Operating, Gross MarginsIINN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024

More info and screens

5

2. Health

2.1 Basic Checks

Compared to 1 year ago, IINN has more shares outstanding
The number of shares outstanding for IINN has been increased compared to 5 years ago.
IINN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IINN Yearly Shares OutstandingIINN Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
IINN Yearly Total Debt VS Total AssetsIINN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

Based on the Altman-Z score of -12.65, we must say that IINN is in the distress zone and has some risk of bankruptcy.
IINN has a Altman-Z score of -12.65. This is amonst the worse of the industry: IINN underperforms 84.57% of its industry peers.
IINN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -12.65
ROIC/WACCN/A
WACCN/A
IINN Yearly LT Debt VS Equity VS FCFIINN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

A Current Ratio of 2.02 indicates that IINN has no problem at all paying its short term obligations.
The Current ratio of IINN (2.02) is worse than 64.89% of its industry peers.
A Quick Ratio of 1.89 indicates that IINN should not have too much problems paying its short term obligations.
IINN has a Quick ratio of 1.89. This is comparable to the rest of the industry: IINN outperforms 49.47% of its industry peers.
Industry RankSector Rank
Current Ratio 2.02
Quick Ratio 1.89
IINN Yearly Current Assets VS Current LiabilitesIINN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

0

3. Growth

3.1 Past

IINN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.02%, which is quite impressive.
EPS 1Y (TTM)36.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-217.55%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IINN Yearly Revenue VS EstimatesIINN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 1M 2M 3M
IINN Yearly EPS VS EstimatesIINN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 -0.5 -1 -1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IINN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IINN Price Earnings VS Forward Price EarningsIINN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IINN Per share dataIINN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for IINN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INSPIRA TECHNOLOGIES OXY BHN

NASDAQ:IINN (6/9/2025, 10:13:12 PM)

Premarket: 0.6902 -0.04 (-5.45%)

0.73

+0 (+0.55%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-11 2025-03-11
Earnings (Next)N/A N/A
Inst Owners4.77%
Inst Owner Change82.57%
Ins Owners6.75%
Ins Owner ChangeN/A
Market Cap18.70M
Analysts82.86
Price Target13.26 (1716.44%)
Short Float %0.45%
Short Ratio0.2
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.33
P/tB 4.33
EV/EBITDA N/A
EPS(TTM)-0.6
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.37
FCFYN/A
OCF(TTM)-0.37
OCFYN/A
SpS0
BVpS0.17
TBVpS0.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -136.96%
ROE -255.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-107.44%
ROA(5y)-223.64%
ROE(3y)-177.51%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 95.91%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.02
Quick Ratio 1.89
Altman-Z -12.65
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)121.61%
Cap/Depr(5y)89.97%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-217.55%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y7.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y4.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y3.92%
OCF growth 3YN/A
OCF growth 5YN/A